Detalles de la búsqueda
1.
Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trial.
Diabetes Obes Metab
; 23(6): 1272-1281, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33528904
2.
Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.
Cardiovasc Diabetol
; 15: 14, 2016 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-26809442
3.
Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial.
Nat Med
; 28(6): 1269-1276, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35551290
4.
Neuropathy and presence of emotional distress and depression in longstanding diabetes: Results from the Canadian study of longevity in type 1 diabetes.
J Diabetes Complications
; 31(8): 1318-1324, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28599823
5.
Prevalence of Insulin Pump Therapy and Its Association with Measures of Glycemic Control: Results from the Canadian Study of Longevity in Type 1 Diabetes.
Diabetes Technol Ther
; 18(5): 298-307, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27023749
6.
Commonly Measured Clinical Variables Are Not Associated With Burden of Complications in Long-standing Type 1 Diabetes: Results From the Canadian Study of Longevity in Diabetes.
Diabetes Care
; 39(5): e67-8, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27006509
Resultados
1 -
6
de 6
1
Próxima >
>>